HIV IN ANÁPOLIS (GO): CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS BEFORE AND AFTER THE COVID-19 PANDEMIC
Keywords:
Sistema Único de Saúde, HIV, AnápolisAbstract
Introduction: The Human Immunodeficiency Virus (HIV) directly attacks the immune system, which functions as the body’s protective shield against diseases, weakening its defenses and making the organism more susceptible to various infections and tumors. Considering that the COVID-19 pandemic posed a significant challenge to the continuity of HIV care, it becomes crucial to analyze its impact on the epidemiological profile of the infection in the municipality of Anápolis.
Objective: The central objective of this project is to describe and compare the clinical and epidemiological characteristics of new HIV cases in the post-pandemic period (2023–2024) with those in the pre-pandemic period (2018–2019), in order to assess whether significant changes occurred in the socio-epidemiological pattern of cases in the municipality.
Methodology: The methodology will consist of an observational, cross-sectional study with a quantitative approach, both retrospective and prospective in nature, using as sources the compulsory notification forms from the National System of Notifiable Diseases (SINAN) and data from DATASUS.
Results: Data analysis will support the development of more effective and targeted public policies, based on a Detailed Action Plan focused on improving prevention, diagnosis, treatment, and quality of life for people living with HIV.
Conclusion: This study represents a crucial step in the fight against HIV in Anápolis, as by unveiling the post-pandemic epidemiological scenario and outlining possibilities for public interventions, it contributes to building a future free of the disease in the city.
References
¹ GARCIA, Sofia Battistini; GUZMAN, Nilmarie. Acquired immune deficiency syndrome CD4+ count. StatPearls, 2023.
² LEITE, Daniela Soares. A AIDS no Brasil: mudanças no perfil da epidemia e perspectivas. Brazilian Journal of Development, v. 6, n. 8, p. 57382-57395, 2020.
³ BRASIL. Ministério da Saúde. Boletim Epidemiológico – HIV e AIDS 2023. Disponível em: https://www.gov.br/aids/pt-br/central-de-conteudo/boletins-epidemiologicos/2023/hiv-aids/boletim-epidemiologico-hiv-e-aids-2023.pdf/view. Acessado em: 30 abr. 2024.
⁴ AMORIM, Thaynara Ferreira; DA SILVA DUARTE, Lucélia. Perfil epidemiológico de casos notificados de HIV no estado de Goiás. Revista Científica da Escola Estadual de Saúde Pública de Goiás "Cândido Santiago", v. 7, p. e7000043-e7000043, 2021.
⁵ RIBEIRO, B. S. et al. Impacto da pandemia de COVID-19 na detecção de casos de AIDS no Brasil. The Brazilian Journal of Infectious Diseases, v. 27, p. 103019, 2023. DOI: 10.1016/j.bjid.2023.103019.
⁶ SOUSA, R. F. V. de et al. Análise das Infecções Sexualmente Transmissíveis durante a pandemia da COVID-19 no Brasil. Revista Eletrônica Acervo Saúde, v. 24, n. 8, e18163, 2024. DOI: 10.25248/reas.e18163.2024.
⁷ SAÚDE COLETIVA. Perfil epidemiológico dos casos de HIV/AIDS em Anápolis-Goiás entre os anos de 2017 a 2022. Saúde Coletiva (Barueri), v. 15, n. 97, p. 16296-16313, 2025. DOI: 10.36489/saudecoletiva.2025v15i97p16296-16313.
⁸ BRASIL. Secretaria de Estado da Saúde. Boletim Epidemiológico, 2024. Disponível em: https://goias.gov.br/saude/wp-content/uploads/sites/34/files/boletins/epidemiologicos/dst-aids/2024/boletim-hiv-aids-2018-2023.pdf.
⁹ BLASSEL, L. et al. Drug resistance mutations in HIV: new bioinformatics approaches and challenges. Current Opinion in Virology, v. 51, p. 56-64, 2021. DOI: 10.1016/j.coviro.2021.09.009.
